Semi-Annual Statement Of Income And Retained Earnings

OncoTherapy Science, Inc. - Filing #7329199

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-910,192,000 JPY
-1,120,800,000 JPY
-210,607,000 JPY
-674,559,000 JPY
-235,633,000 JPY
-889,202,000 JPY
-690,746,000 JPY
-34,385,000 JPY
-725,131,000 JPY
-1,086,031,000 JPY
-381,283,000 JPY
-1,106,415,000 JPY
Non-operating income
Non-operating income
26,000 JPY
30,742,000 JPY
26,958,000 JPY
576,000 JPY
Non-operating expenses
Non-operating expenses
15,599,000 JPY
14,896,000 JPY
27,161,000 JPY
27,260,000 JPY
Ordinary profit (loss)
-1,136,373,000 JPY
-873,356,000 JPY
-1,086,234,000 JPY
-1,133,099,000 JPY
Extraordinary income
Extraordinary income
5,225,000 JPY
269,528,000 JPY
38,186,000 JPY
38,231,000 JPY
Extraordinary losses
Extraordinary losses
154,564,000 JPY
402,744,000 JPY
68,146,000 JPY
21,553,000 JPY
Profit (loss) before income taxes
-1,285,713,000 JPY
-1,006,572,000 JPY
-1,116,193,000 JPY
-1,116,420,000 JPY
Income taxes - current
2,425,000 JPY
1,210,000 JPY
1,321,000 JPY
2,561,000 JPY
Income taxes - deferred
JPY
JPY
-338,000 JPY
-338,000 JPY
Profit (loss)
-1,007,782,000 JPY
-1,288,138,000 JPY
-1,007,782,000 JPY
-1,007,782,000 JPY
-1,007,782,000 JPY
-1,117,177,000 JPY
-1,117,177,000 JPY
-1,117,177,000 JPY
-1,117,177,000 JPY
-1,118,644,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.